Navigation Links
Adeona Reports Second Quarter 2011 Financial Results
Date:8/15/2011

EN-100 as a treatment for Alzheimer's, the failure of reaZin or wellZin to be accepted for either use, failure of future clinical trials of any of our drug candidates to be enrolled in and completed in the anticipated time or to achieve the desired results, and other factors described in Adeona's report on Form 10-K for the year ended December 31, 2010 and any other filings with the SEC. The information in this release is provided only as of the date of this release, and Adeona undertakes no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.


'/>"/>
SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Adeona to Host Second Quarter 2011 Investor Conference Call
2. Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrigs Disease (ALS)
3. Adeona Reports 1st Quarter 2011 Financial Results
4. Adeona to Host First Quarter 2011 Investor Conference Call
5. Adeona Executes Manufacturing and Supply Agreement with TG United for reaZin™
6. Adeonas Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper
7. Adeona to Host Conference Call
8. Adeona to Raise $3.5 Million in Registered Direct Offering
9. Adeona Reports 2010 Year End Financial Results
10. Adeona to Host 2010 Year End Investor Conference Call
11. Adeonas Multiple Sclerosis Trial Receives $409,426 Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Leading events organizer UBM Live announces that CPhI ... São Paulo, Brazil from 5 th ... co-locate with Food Ingredients South America (FiSA), creating ... pharmaceutical industry.      (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a) Three ... exploring the South America market as ...
(Date:7/24/2014)... 2014   AcelRx Pharmaceuticals, Inc.  (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... date for Zalviso remains July 27, 2014.  ... stating the Food and Drug Administration (FDA) had approved ... no notification to the company from the FDA regarding ...
(Date:7/24/2014)... MARSEILLE , Frankreich, July ... , Weltweite Exklusivlizenz der Universität ... Entwicklung von Tests auf SF3B1-Mutationen, einschließlich von ... Neuer Test weist Mutationen des SF3B1-Gens nach, ... einen günstigen Krankheitsverlauf vermuten lassen  ...
Breaking Medicine Technology:CPhI South America 2014 Launches with Generics Showing Huge Growth 2CPhI South America 2014 Launches with Generics Showing Huge Growth 3CPhI South America 2014 Launches with Generics Showing Huge Growth 4AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date for Zalviso 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
(Date:7/25/2014)... 25, 2014 Eye & Vision has ... their office location by expanding a new specialized ocular ... comprehensive visual electro-physiology clinic. , By acquiring specialized Visual ... experience in vision problems, patients with vision loss in ... advantage of the implementation of this specialized vision testing ...
(Date:7/25/2014)... The European liquid chromatography reagents report defines and ... forecast of revenue. The liquid chromatography reagents market in ... and is estimated to grow to around $1581.8 million ... 2013 to 2018. , Browse through the TOC of ... idea of the in-depth analysis provided. This also provides ...
(Date:7/25/2014)... FRIDAY, July 25, 2014 (HealthDay News) -- Twins, genes ... their environment, according to a new study. ... vocabulary, putting words together and grammar, were largely inherited. ... that the "twinning effect" (a lower level of language ... identical twins than non-identical twins. "This finding disputes ...
(Date:7/25/2014)... -- A protein that controls when genes are switched ... areas of the brain to regulate metabolism, UT Southwestern ... lead to new therapies to treat obesity and diabetes, ... protein 1 (Xbp1s) appears to influence the body,s ... are hormones central to the body,s regulation of food ...
(Date:7/25/2014)... 2014 The American Brain Tumor Association ... Development Trainer of Distinguished Events, and Corporate and Special ... Cancer Society, will be joining the ABTA in the ... will oversee the roll out of a nationwide brain ... The recently launched volunteer network will provide the Chicago-based ...
Breaking Medicine News(10 mins):Health News:Eye & Vision, a Leading Eye Doctor Group in Richardson, Celebrate Milestone and Expand Scope of Specialized Eye Care 2Health News:Eye & Vision, a Leading Eye Doctor Group in Richardson, Celebrate Milestone and Expand Scope of Specialized Eye Care 3Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Genes May Be Key to Language Delay in Kids 2Health News:Manipulating key protein in the brain holds potential against obesity and diabetes 2Health News:American Brain Tumor Association Recruits Director to Lead New Volunteer Network 2
... Pradesh government has decided to prepone the Japanese Encephalitis immunisation ... the centre// as they feel that it might not be ... ,It has been decided that the immunisation campaign ... undertaken on May 15, 2006 itself. 5.2 million doses of ...
... to aid the formation of insulin crystals in the ... of Houston professor and his student, which holds promise ... ,Peter Vekilov, associate professor of chemical engineering, ... engineering, both in UH's Cullen College of Engineering, have ...
... the Arab world is awakening to the growing menace of ... especially true in Dubai//. ,In order to effectively deal ... are addressing this problem openly and stressing on the adverse ... that more and more officials and religious leaders were stressing ...
... from arthritis face increased risk of fractures in later ... M. Burnham of The Children's Hospital of Philadelphia and ... in Britain who had first experienced arthritis between ages ... patients to a larger control group of 207,000 patients ...
... recent study, women who use the contraceptive pill, Dianette, ... of developing depression//. ,Adverse Psychiatric Reactions Information Link, ... effective contraceptive licensed as a hormone treatment for acne, ... ,The women said they experienced serious depression while ...
... insurance plans show wide variations among different states with ... ,-Employees in the smallest firms (1-9 workers) ... than those in the largest firms (1,000+ workers), when ... a health plan--is taken into account, a new Commonwealth ...
Cached Medicine News:Health News:Uttar Pradesh To Prepone The Japanese Encephalitis Immunisation Drive 2Health News:Uttar Pradesh To Prepone The Japanese Encephalitis Immunisation Drive 3Health News:Insulin Crystals Holds Promise In Diabetes research 2Health News:Health Insurance Plans Varies among States 2Health News:Health Insurance Plans Varies among States 3
Performa cemented stem....
M2 cemented hip stem....
Porous foundation 480 series....
Cemented foundation 460 series....
Medicine Products: